Cite
HARVARD Citation
Schwartzberg, L. et al. (n.d.). Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial. Lancet oncology. 16 (9), pp. 1071-1078. [Online].